ADAPTIVE THERAPEUTICS

Serial Number 87380024
602

Registration Progress

Application Filed
Mar 21, 2017
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ADAPTIVE THERAPEUTICS
Previous Owner: Adaptive Biotechnologies
Classes: 042

Trademark Image

ADAPTIVE THERAPEUTICS

Basic Information

Serial Number
87380024
Filing Date
March 21, 2017
Abandonment Date
July 30, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Aug 30, 2018
Classes
042

Rights Holder

Adaptive Biotechnologies

03
Address
1551 Eastlake Avenue E, Suite 200
Seattle, WA 98102

Ownership History

Adaptive Biotechnologies

Original Applicant
03
Seattle, WA

Legal Representation

Attorney
Hoang-chi Truong

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

26 events
Date Code Type Description Documents
Aug 30, 2018 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Aug 30, 2018 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 29, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 13, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 29, 2018 GNS1 O NOTIFICATION OF SUBSEQUENT FINAL EMAILED Loading...
Jan 29, 2018 GNSF O SUBSEQUENT FINAL EMAILED Loading...
Jan 29, 2018 CFRC R SUBSEQUENT FINAL REFUSAL WRITTEN Loading...
Dec 16, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 15, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 15, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 12, 2017 GAUN O NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED Loading...
Oct 12, 2017 GAUD O NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED Loading...
Oct 12, 2017 NAUD R REPORT UNRESPONSIVE AMENDMENT - COMPLETED Loading...
Aug 26, 2017 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Aug 26, 2017 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 26, 2017 CNFR R FINAL REFUSAL WRITTEN Loading...
Aug 2, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 2, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 31, 2017 ALIE A ASSIGNED TO LIE Loading...
Jun 27, 2017 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jun 21, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 21, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 21, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 14, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 24, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research, development and analytical services for discovery and identification of T-cell receptor sequences specific for an antigen or for development or use as a therapeutic, therapeutic target or biomarker; scientific research, development, and analytical services in the fields of medicine, oncology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune repertoire sequencing, T-cell therapeutics, therapeutics, and therapeutic technologies
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042